Catalysts in Science

STAT Brand Studio

0.0 (0)
Business

Catalysts in Science explores the ideas and leaders shaping the future of health care, medicine, and the life sciences. Scientists, executives, clinicians, and other experts discuss the breakthroughs, research, and decisions moving their fields forward. Episodes are produced by STAT Brand Studio as sponsored content.

Apr 16

How unmet patient needs are shaping the next phase of cancer research

Oncology leaders Jackson Egen of Gilead Sciences and Priti Hegde of Kite, a Gilead company, discuss how unmet patient needs are shaping the next phase of cancer research. They explore how Gilead and Kite are approaching oncology across multiple fronts, drawing on advances in blood cancers and applying those lessons to solid tumors such as glioblastoma, alongside continued progress in cell therapy and other biology‑driven therapeutic approaches. Moderated by Jesse McQuarters. Read more: https://www.statnews.com/sponsor/2026/04/16/how-unmet-patient-needs-are-shaping-the-next-phase-of-cancer-research/ Image credit: Radhika Patnala/Endosymbiont GmBH

7 min
Mar 20

Could U.S. policy clinch China’s grip on biotech?

Drug pricing reforms were meant to protect patients — but they may also be reshaping where innovation happens. In this interview, John Stanford of Incubate explains how MFN price controls and regulatory uncertainty ripple through the biotech ecosystem, squeezing small innovators and pushing investment abroad. Moderated by Terzel Vasquez, Producer, STAT Brand Studio. Read more: https://www.statnews.com/sponsor/2026/03/04/could-u-s-policy-clinch-chinas-grip-on-biotech/

12 min
Feb 24

Astellas CEO talks transformative medicines driving growth

At the 2026 JPM Conference in San Francisco, Astellas President and CEO Naoki Okamura spoke with STAT Brand Studio Editor Jesse McQuarters about the company’s strategy and long-term vision as it enters an important phase in the company’s evolution. Astellas is taking a patient-centered approach and investing in four key areas within R&D — targeted protein degradation, immuno-oncology, blindness and regeneration, and genetic regulation — as it prepares for the loss of exclusivity of its leading prostate cancer therapy. Read more here: https://www.statnews.com/sponsor/2026/02/23/astellas-ceo-talks-transformative-medicines-driving-growth/

6 min
Feb 20

Bridging gaps in asthma care

People living with asthma understand that their environment affects their health, but they’re often left without the tools, guidance, or support to fully act on that knowledge. In this virtual event, Chiesi unveils findings from its recent Asthma Community Survey, which looks at this fundamental gap and potential solutions. In particular, this conversation explores how embedding Environmental Health Literacy (EHL) into clinical, community, and digital systems can help individuals navigate air quality improvements with greater confidence, and panelists lay out a roadmap for building more responsive, patient-centered asthma care. • Anju T. Peters, M.D. M.SCI, Professor of Medicine, Director of Clinical Research, Division of Allergy and Immunology, Director, Center for Clinical Research, Northwestern University Clinical and Translational, Sciences Institute (NUCATS), Medical Director, Northwestern Medicine Clinical Research Unit, Northwestern University Feinberg School of Medicine • Cindy Trubisky, M.Ed., AE-C, Senior Director, Nationwide Health Promotions, Asthma Programs, American Lung Association • Jesse McQuarters, Editor, STAT Brand Studio Read more: https://www.statnews.com/sponsor/2025/12/01/do-enough-allergists-and-pcps-know-about-environmental-health-literacy/

27 min
12/04/2025

How proteomics and multi-omics are deepening our understanding of human health

In this collaborative episode of The Nucleus, Dr. John Overton, vice president and chief sequencing officer at Regeneron Genetics Center (RGC), joins STAT Brand Studio’s Jesse McQuarters to explore how integrating proteomics and multi-omics can deliver deeper insight into how diseases develop — and how science can better predict and prevent them.

20 min
10/09/2025

“Taking possibility back” across oncology’s toughest frontiers

What does it take to transform the outlook for patients facing some of the most difficult cancers? Dr. Dietmar Berger, Chief Medical Officer at Gilead Sciences, shares how the company is tackling urgent needs in triple negative breast cancer (TNBC) and pioneering the next generation of CAR-T therapies to reshape what’s possible in oncology. Read more: https://www.statnews.com/sponsor/2025/10/09/taking-possibility-back-across-oncologys-toughest-frontiers/ Photo: Radhika Patnala/Endosymbiont GmBH

7 min
09/18/2025

Can provider education and smarter policy close the biosimilars gap?

Biosimilars are driving down drug costs, expanding access to critical treatments, and creating space for future innovation. In this episode, Linda Choi MacDonald, EVP and Global Head of Commercial at Samsung Bioepis, discusses the challenges slowing biosimilar development — and how policy reforms, stronger incentives, and provider education can help close the gap. Read more: https://www.statnews.com/sponsor/2025/09/18/can-provider-education-and-smarter-policy-close-the-biosimilars-gap/

7 min
08/25/2025

From research to advocacy: A new fellowship honors Stephen Harrison’s vision in MASH research

The sudden passing of Dr. Stephen Harrison in 2024 marked the loss of a visionary liver disease researcher and compassionate advocate. His legacy lives on through a new fellowship program that aims to educate and empower patient advocates in MASH. Led by the Fatty Liver Foundation with support from Madrigal Pharmaceuticals as a founding sponsor, the program reflects Dr. Harrison’s belief that centering patients in research can elevate liver disease care for generations to come. Read more: https://www.statnews.com/sponsor/2025/08/25/empowering-patients-to-shape-the-future-of-mash-care/↗ Guests: Wayne Eskridge — Founder and CEO, Fatty Liver Foundation Dr. Maru Rinella — Professor of Medicine and Director, Metabolic and Fatty Liver Disease program, University of Chicago Dr. Becky Taub — Founder and Senior Scientific & Medical Advisor, Madrigal Pharmaceuticals Moderator: Jesse McQuarters — Editor, STAT Brand Studio

24 min

Catalysts in Science explores the ideas and leaders shaping the future of health care, medicine, and the life sciences. Scientists, executives, clinicians, and other experts discuss the breakthroughs, research, and decisions moving their fields forward. Episodes are produced by STAT Brand Studio as sponsored content.

Creator

STAT Brand Studio
Years Active

2024 - 2026
Episodes

15
Rating

Clean
Show Website

Catalysts in Science